Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Reexamination Certificate
2007-02-02
2010-02-02
Sheikh, Humera N (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
C424S451000, C424S457000, C424S464000, C424S468000, C424S489000, C424S497000
Reexamination Certificate
active
07655259
ABSTRACT:
A sustained release, orally administered pharmaceutical composition comprising carnitine and an acceptable pharmaceutical excipient is described for the treatment of carnitine deficiency and other carnitine responsive conditions. The sustained release formulation avoids the characteristic problems of gastrointestinal invitation, dumping in the urine and bacterial degradation attendant previously known oral formulations of carnitine.
REFERENCES:
patent: 3810994 (1974-05-01), Wiegand
patent: 4681755 (1987-07-01), Colombo et al.
patent: 4871550 (1989-10-01), Millman
patent: 5178878 (1993-01-01), Wehling et al.
Gulbrandsen Carl E.
Shug Austin L.
Lucas & Mercanti LLP
Sheikh Humera N
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A
LandOfFree
Delayed release carnitine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delayed release carnitine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delayed release carnitine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191793